Skip to main content
SpringerLink
Log in

Liposomal dry powders as aerosols for pulmonary delivery of proteins

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The purpose of this research was to develop liposomal dry powder aerosols for protein delivery. The delivery of stable protein formulations is essential for protein subunit vaccine delivery, which requires local delivery to macrophages in the lungs. β-Glucuronidase (GUS) was used as a model protein to evaluate dry powder liposomes as inhaled delivery vehicles. Dimyristoyl phosphatylcholine:cholesterol (7∶3) was selected as the liposome composition. The lyophilization of liposomes, micronization of the powders, aerosolization using a dry powder inhaler (DPI), and in vitro aerodynamic fine particle fraction upon collection in a twinstage liquid impinger were evaluated. After lyophilization and jet-milling, the total amount of GUS and its activity, representing encapsulation efficiency and stability, were evaluated. The GUS amount and activity were measured and compared with freshly-prepared liposomes in the presence of mannitol, 43% of initial GUS amount, 29% of GUS activity after lyophilization and 36% of GUS amount, 22% of activity after micronization were obtained. Emitted doses from dry powder inhaler were 53%, 58%, 66%, and 73% for liposome powder:mannitol carrier ratios of 1∶0, 1∶4, 1∶9, and 1∶19. Fifteen percent of the liposome particles were less than 6.4 μm in aerodynamic diameter. The results demonstrate that milled liposome powders containing protein molecules can be aerosolized effectively at a fixed flow rate. Influences of different cryoprotectants on lyophilization of protein liposome formulations are reported. The feasibility of using liposomal dry powder aerosols for protein delivery has been demonstrated but further optimization is required in the context of specific therapeutic proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ahmed T, ed. Clinical testing of aerosol drugs.Respiratory Drug Delivery. Boca Raton, FL: CRC Press; 1990:208–242.

    Google Scholar 

  2. Schreier H, Gonzales-Rothi RJ, Stecenko AA. Pulmonary delivery of liposomes.J Control Release. 1993;24:209–223.

    Article  CAS  Google Scholar 

  3. Zeng XM, Martin GP, Marriott C. The controlled drug delivery to the lung.Int J Pharm. 1995;124:149–164.

    Article  CAS  Google Scholar 

  4. Gilbert BE, Wyde PR, Wilson SZ, Robins RK. Aerosol and intraperitoneal administration of ribavarin and ribavarin triacetate: pharmacokinetics and protection of mice against intracerebral infection with influenza A/WDN virus.Antimicrob Agents Chemother. 1991;35:1448–1453.

    CAS  Google Scholar 

  5. Parthasarathy R, Gilbert B, Mehta K. Aerosol delivery of liposomal all-trans retinoic acid to the lungs.Cancer Chemother Pharmacol. 1999;43:277–283.

    Article  CAS  Google Scholar 

  6. Suntres ZE, Shek PN. Alleviation of paraquat-induced lung injury by pretreatment with bifunctional liposomes containing α-tocopherol and glutathione.Biochem Pharmacol. 1996;52:1515–1520.

    Article  CAS  Google Scholar 

  7. Briscoe P, Caniggia I, Graves A, et al. Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes.Am J Physiol. 1995;268:L374-L380.

    CAS  Google Scholar 

  8. Thibeault DW, Rezaiekhaligh M, Mabry S, Beringer T. Prevention of chronic pulmonary oxygen toxicity in young rats with liposome-encapsulated catalase administered intratracheally.Pediatr Pulmonol. 1991;11:318–327.

    Article  CAS  Google Scholar 

  9. Saari M, Vidgren MT, Kiskinen MO, Turjanmaa VHM, Neiminen MM. Pulmonary distribution and clearance of 2 beclomethasone liposome formulations in healthy volunteers.Int J Pharm. 1999;181:1–9.

    Article  CAS  Google Scholar 

  10. Lange CF, Hancock REW, Samuel J, Finlay WH. In vitro delivery and regional airway surface liquid concentration of a liposomal cationic peptide.J Pharm Sci. 2001;90:1647–1657.

    Article  CAS  Google Scholar 

  11. Niven RW, Speer M, Schreier H. Nebulization of liposomes. I. Effects of lipid compositions.Pharm Res. 1992;9:515–520.

    Article  CAS  Google Scholar 

  12. Hickey AJ, Dunbar CA. A new millennium for inhaler technology.Pharm Technol. 1997;21:116–125.

    Google Scholar 

  13. Shreier H, Mobley WC, Concessio N, Hickey AJ, Niven RW. Formulation and in vitro performance of liposome powder aerosols.STP Pharma Sciences. 1997;4:38–44.

    Google Scholar 

  14. Lo Y, Tsai J, Kuo J. Liposomes and saccharides as carriers in spraydried powder formulations of superoxide dismutase.J Control Release. 2004;94:259–272.

    Article  CAS  Google Scholar 

  15. Joshi MR, Misra A. Liposomal budesonide for dry powder inhaler: preparation and stabilization.AAPS PharmSciTech. 2001;2:E25.

    Article  Google Scholar 

  16. Joshi M, Misra A. Disposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lung.Clin Exp Pharmacol Physiol. 2003;30:153–156.

    Article  CAS  Google Scholar 

  17. Jendle JH, Karlberg B, Arborelius M. An exploration of intrapulmonary insulin administration in anaesthetized and mechanically ventilated pigs.Scand J Clin Lab Invest. 1996;56:251–258.

    Article  CAS  Google Scholar 

  18. Patton JS, Trinchero P, Platz RM. Bioavailability of pulmonary delivered peptides and proteins: α-interferon, calcitonins, and parathyroid hormone.J Control Release. 1994;28:79–85.

    Article  CAS  Google Scholar 

  19. Colthorpe P, Farr SJ, Smith IJ, Wyatt D, Taylor G. The influence of regional deposition on the pharmacokinetics of pulmonary-delivered human growth hormone in rabbits.Pharm Res. 1995;12:356–359.

    Article  CAS  Google Scholar 

  20. Lizio R, Klenner T, Borchard G, et al. Systemic delivery of the GnRH antagonist cetrorelix by intratracheal instillation in anesthetized rat.Eur J Pharm Sci. 2000;9:253–258.

    Article  CAS  Google Scholar 

  21. Folkesson HG, Westrom BR, Pierzynowski SG, Svendsen J, Karlsson BW. Lung to blood passage of albumin and a nonapeptide after intratracheal instillation in the young developing pig.Acta Physiol. Scand. 1993;147:173–178.

    Article  CAS  Google Scholar 

  22. Russo DM, Kozlova N, Lakey DL, Kernodle D. Naive human T cells develop into Th1 effectors after stimulation with mycobacterium tuberculosis-infected macrophages or recombinant Ag85 proteins.Infect Immun. 2000;68:6826–6832.

    Article  CAS  Google Scholar 

  23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent.J Biol Chem. 1951:193:265–275.

    CAS  Google Scholar 

  24. Combie J, Blake JW, Nugent TE, Tobin T. Morphine glucuronide hydrolysis: superiority of beta-glucuronidase from patella vulgata.Clin Chem. 1982;28:83–86.

    CAS  Google Scholar 

  25. Fisherman WH. Methods for determination of enzyme activity-III Hydrolases: β-Glucuronidase. In: Bergmeywe HU, ed.Methods of Enzymatic Analysis Volume 2, 2nd ed. New York, NY: Academic Press, Inc; 1974:929–943.

    Google Scholar 

  26. Stewart JC. Colorimetric determination of phospholipids with ammonium ferrothiocyanate.Anal Biochem. 1980;104:10–14.

    Article  CAS  Google Scholar 

  27. Leonard A, Dufourc EJ. Interactions of cholesterol with the membrane lipid matrix: a solid state NMR approach.Biochimie. 1991;73:1295–1302.

    Article  CAS  Google Scholar 

  28. Colletier JP, Chaize B, Winterhalter M, Fournier D. Protein encapsulation in liposomes: efficiency depends on interaction between protein and phospholipid bilayer.BMC Biotechnol. 2002;2:9–17.

    Article  Google Scholar 

  29. Flores H, Ellington AD. Increasing the thermal stability of an oligomeric protein, beta-glucuronidase.J Mol Biol. 2002;315: 325–337.

    Article  CAS  Google Scholar 

  30. Hellman K, Miller DS, Cammack KA. The effects of freeze-drying on the quaternary structure of L-asparaginase from Erwinia Carotovora.Biochim Biophys Acta 1983;749:133–142.

    CAS  Google Scholar 

  31. Clark AR, Egan M. Modeling the deposition of inhaled powdered drug aerosols.J Aerosol Sci. 1994;25:175–186.

    Article  Google Scholar 

  32. The United States Pharmacopeial Convention.The United States Pharmacopoeia and National Formulary. USP24. Rockville, MD: United States Pharmacopoeial Convention; 2000:1895–1912.

    Google Scholar 

  33. Hickey AJ, Swift D. Measurements of Pharmaceutical Diagnostic Aerosols. In: Baron PA, Willeke K, eds.Aerosol Measurement: Principles, Techniques and Applications. New York: Wiley; 2001:1031–1052.

    Google Scholar 

  34. Bell JH, Hartley PS, Cox JSG. Dry powder aerosols. I. A new powder inhalation device.J Pharm Sci. 1971;60:1559–1564.

    Article  CAS  Google Scholar 

  35. van Winden EC, Zhang W, Crommelin DJ. Effect of freezing rate on the stability of liposomes during freeze-drying and rehydration.Pharm Res. 1997;14:1151–1160.

    Article  Google Scholar 

  36. Hatley RHM, Blair JA. Stabilization and delivery of labile materials by amorphous carbohydrates and their derivatives.J Mol Catal, B Enzym. 1999;7:11–19.

    Article  CAS  Google Scholar 

  37. Zeng XM, Martin GP, Marriot C. Effects of molecular weight of polyvinylpyrrolidone on the glass transition and crystallization of co-lyophilized sucrose.Int J Pharm. 2001;218:63–73.

    Article  CAS  Google Scholar 

  38. Shamblin SL, Huang EY, Zografi G. The effects of co-lyophilized polymeric additives on the glass transition temperature and crystallization of amorphous sucrose.J Therm Anal. 1996;47:1567–1579.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Pharmacy, CB#7360, University of North Carolina at Chapel Hill, Kerr Hall 1311, 27599, Chapel Hill, NC

    Dongmei Lu & Anthony J. Hickey

Authors
  1. Dongmei Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony J. Hickey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony J. Hickey.

Additional information

Published: December 21, 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lu, D., Hickey, A.J. Liposomal dry powders as aerosols for pulmonary delivery of proteins. AAPS PharmSciTech 6, 80 (2005). https://doi.org/10.1208/pt060480

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt060480

Keywords

Search

Navigation